Skip to main content
OpenTrials
Completed

NCT Number: NCT04937179

The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD

Lower limb amputation is common in the United States, with approximately 150,000 amputations annually. Most individuals walking with a prosthesis demonstrate asymmetrical loading-i.e., they favor the amputated side by placing more weight and increased ground reaction forces through the intact limb-which likely contributes to increased metabolic cost of walking. Lack of adequate muscular strength in the lower limb to attenuate these forces places increased stress on the joints, which may be displaced proximally, and may play a role in reported knee and hip pain in the intact limb.

Lower limb muscle weakness following amputation has been well documented. Increasing quadriceps strength is important after an amputation because it is positively correlated with gait speed. Gait speed may also be associated with successful community mobility, which leads to improved quality of life following amputation. Individuals with amputation who resume an active lifestyle are able to maintain strength. However, these individuals represent a minority of persons with lower limb amputation; most individuals report more barriers than motivators to adopt an active lifestyle.

Ischemic conditioning (IC) may strengthen leg muscles and reduce the metabolic cost of activity after amputation. In IC, the limb is exposed to brief, repeated bouts of ischemia (reduced blood flow) immediately followed by reperfusion. IC has been shown to improve muscle performance in healthy and diseased populations. IC has also been used more recently in patients with peripheral artery disease (PAD) as an intervention to improve function, such as walking ability. Acute exposure to IC increases muscle strength and activation, both in healthy, active individuals and in those with severe neuromuscular dysfunction, such as stroke survivors. IC also attenuates muscular fatigue. Increased fatigue resistance at submaximal contraction levels following IC may be due to increased neural activation of skeletal muscle. Changes in neural activation of muscle may be particularly beneficial during cortical reorganization after amputation. Reduced quadriceps fatigue during submaximal activities may also drive changes in gait kinematics, such as increased knee flexion during loading and mid-stance. Exposure to IC may also increase the oxidative properties of skeletal muscle, offering a direct pathway to reduce metabolic cost. Therefore, IC may lead to cellular changes that lower the metabolic cost of activity.

The primary aim of this study is to quantify the benefits of acute and chronic IC on quadriceps strength and walking economy in individuals with PAD and history of lower limb amputation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UIC Physical Therapy Faculty Practice

Chicago, Illinois, 60608, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Able to ambulate independently without the use of aids (i.e., walking cane)
  • Able to walk at least 10 minutes continuously without stopping
  • History of diagnosed peripheral artery disease.
  • For Amputees: History lower limb unilateral transtibial or transfemoral amputation.

Exclusion criteria

  • Inability to give informed consent
  • neurological disorder that affects gait
  • two or more falls within the previous 12 months
  • currently pregnant (or intend to become pregnant while participating in study)
  • history of any condition where fatiguing contractions or resisted leg contractions are contraindicated
  • blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg).
  • history of hypertension
  • history of heart failure
  • Head injury within the previous 6 months
  • Seizure disorder
  • Adverse reaction to ultrasound gel
  • History of thrombosis
  • History of sickle cell trait

Treatment and study plan

Ischemic Conditioning Low - Sham Comparator

Procedure

The use of a Hokanson rapid inflator cuff to restrict blood flow at 25mmHg for 5 minutes followed by a 5 minute reperfusion period, repeated for 5 cycles.

Ischemic Conditioning High - Active Comparator

Procedure

The use of a Hokanson rapid inflator cuff to restrict blood flow at 225mmHg for 5 minutes followed by a 5 minute reperfusion period, repeated for 5 cycles.

Primary outcomes

  1. Change in quadriceps strength

    Time frame: through study completion, an average of 6 weeks

    Quadriceps strength assessed by a Biodex dynamometer

  2. Change in gait kinematics

    Time frame: through study completion, an average of 6 weeks

    Gait mechanics assessed by joint angles using Vicon cameras and reflective markers

  3. Change in gait kinetics

    Time frame: through study completion, an average of 6 weeks

    Gait mechanics assessed by joint forces using a Bertec instrumented treadmill in combination with gait kinematics

  4. Change in gait metabolics

    Time frame: through study completion, an average of 6 weeks

    Assessment of oxygen consumption during walking using a metabolic cart

Secondary outcomes

  1. Six-minute walk test

    Time frame: through study completion, an average of 6 weeks

    Measurement of distance walked in six minutes

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Collaborators

  • American Heart Association

Registry information

Official study title

The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with Peripheral Artery Disease (PAD)

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jun 23, 2021
Registry last updated
Feb 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.